Clinical Research Detail Title Of Study The purpose of this study is to evaluate the efficacy and safety of 2 different doses of canagliflozin compared with placebo in patients with type 2 diabetes mellitus who are receving treatment with metformin and pioglitazone and have inadequate glycemic (blood sugar) control Disease Condition Diabetes Mellitus, Type 2 Phase of Trial Phase-3 Discipline Diabetology Start date of Trial 4/13/2010 Closing Date of Trial 4/13/2012 If you are a doctor interested in clinical research then upload your profile. Click here If you are a hospital interested in clinical research then upload your profile. Click here If you are a patient interested to know more about this clinical trial mail us at:   [email protected]